Pharmabiz2h
Onco-Innovations’ licensed technology demonstrates promise to enhance chemotherapy effectiveness by overcoming cancer cell resistance
Onco-Innovations’ licensed technology demonstrates promise to enhance chemotherapy effectiveness by overcoming cancer cell resistance: Vancouver, BC Saturday, February 1, 2025, ...
Pharmabiz8h
Daiichi Sankyo appoints Hiroyuki Okuzawa as chief executive officer
Daiichi Sankyo appoints Hiroyuki Okuzawa as chief executive officer: Tokyo Saturday, February 1, 2025, 12:30 Hrs [IST] ...
Pharmabiz5h
Angle announces new results for dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform
Angle announces new results for dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform: London Saturday, February 1, 2025, 15:00 Hrs [IST] Angle plc, a wo ...
Pharmabiz4h
Celltrion’s Avtozma, a biosimilar to Actemra receives US FDA approval to treat RA, GCA, pJIA, sJIA and Covid-19
Jersey City, New Jersey Saturday, February 1, 2025, 16:00 Hrs [IST] ...
Pharmabiz4h
Budget 2025 proposes to transform cancer care, medical education, and global healthcare leadership: Experts
Budget 2025 proposes to transform cancer care, medical education, and global healthcare leadership: Experts: Our Bureau, Mumbai Saturday, February 1, 2025, 15:40 Hrs [IST] The Uni ...
Pharmabiz3h
Union budget 2025 defeats the objective of Make in India programme: KDPMA
Union budget 2025 defeats the objective of Make in India programme: KDPMA: Nandita Vijayasimha, Bengaluru Saturday, February 1, 2025, 17:20 Hrs [IST] The Karnataka Drugs and Pharm ...
Pharmabiz3h
Telix Pharma completes acquisition of next-generation therapeutic assets & innovative biologics technology platform of ImaginAb
Telix Pharma completes acquisition of next-generation therapeutic assets & innovative biologics technology platform of ImaginAb: Melbourne, Australia Saturday, February 1, 2025, 1 ...
Pharmabiz3h
Indian pharma gives thumbs up to Budget’s Manufacturing Mission & classification of MSME criteria
Indian pharma gives thumbs up to Budget’s Manufacturing Mission & classification of MSME criteria: Our Bureau, Bengaluru Saturday, February 1, 2025, 16:45 Hrs [IST] India pharma ...
Pharmabiz3h
Health budget witnesses 9.7% growth, experts laud decisions related to healthcare
Health budget witnesses 9.7% growth, experts laud decisions related to healthcare: Our Bureau, New Delhi Saturday, February 1, 2025, 17:05 Hrs [IST] The Union Budget 2025 has prop ...
Pharmabiz4h
Medical devices industry disappointed over Union Budget 2025
With the Union Budget 2025 skipped mentioning medical devices sector directly or addressing the industry demands including custom duty structure, the industry associations said that they are ...
Pharmabiz5h
Customs duty exemption in Budget for cancer drugs, rare diseases including SMA
Customs duty exemption in Budget for cancer drugs, rare diseases including SMA: Our Bureau, New Delhi Saturday, February 1, 2025, 15:20 Hrs [IST] The 36 life saving drugs and medi ...
Pharmabiz6h
Vertex Pharmaceuticals’ suzetrigine gets US FDA approval for treatment of adults with moderate-to-severe acute pain
Vertex Pharmaceuticals’ suzetrigine gets US FDA approval for treatment of adults with moderate-to-severe acute pain: Boston Saturday, February 1, 2025, 14:00 Hrs [IST] Vertex Ph ...